Se prevé que el mercado de vacunas para viajes alcance los 5.914,22 millones de dólares en 2028, frente a los 3.078,94 millones de dólares en 2021. Se estima que crecerá a una tasa compuesta anual del 9,8% de 2021 a 2028.
Las vacunas de viaje, también llamadas inmunizaciones de viaje, son vacunas que los viajeros pueden recibir antes de visitar ciertas regiones del mundo, que ayudan a protegerlos de infecciones y enfermedades graves comunes en las zonas a las que se dirige el viajero. Las vacunas de viaje son formas seguras y eficaces de proteger a los viajeros de traer a casa infecciones que pueden provocar endemias o brotes. Su objetivo es proteger a los viajeros y prevenir brotes de enfermedades dentro y entre países. Algunos países incluso exigen prueba de vacunación a los viajeros que viajan hacia o desde un país. El rápido crecimiento del sector de viajes y turismo y la creciente incidencia de enfermedades infecciosas contribuyen al progreso del mercado. Sin embargo, el alto costo de las vacunas para viajes obstaculiza el crecimiento del mercado de vacunas para viajes.
El mercado de vacunas para viajes se evalúa en función del producto, la aplicación y la geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe de mercado de vacunas para viajes ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como el tamaño del mercado de vacunas para viajes, las tendencias del mercado, los avances tecnológicos y la dinámica del mercado, junto con el análisis del panorama competitivo de los principales actores del mercado. /p>
Perspectivas estratégicas
Se espera que el crecimiento del tamaño del mercado de vacunas para viajes crezca debido al aumento de los viajes y el turismo, la prevención de infecciones transnacionales y la creciente incidencia de enfermedades infecciosas. Sin embargo, se espera que el alto costo de las vacunas para viajes obstaculice el crecimiento del mercado de vacunas para viajes.
regiones lucrativas en el mercado de vacunas para viajes
< br />
Perspectivas del mercado
Aumento de los viajes y las ventas El turismo impulsa el mercado de vacunas para viajes
A medida que los viajes y el turismo se han convertido en una parte integral del estilo de vida humano, la industria de viajes y turismo ha florecido considerablemente. Los viajes y el turismo no sólo han añadido un cambio en la rutina actual de las personas, sino que también han ofrecido oportunidades para explorar diferentes culturas, tradiciones, espiritismo y turismo médico. Según una encuesta realizada por The Millennial Travel Study de Skyscanner, se interrogó a más de 1.000 millennials (de entre 18 y 35 años) sobre factores como su destino preferido, modo de viaje e intereses; la encuesta mostró que una proporción importante de Los encuestados prefirieron viajar a destinos internacionales a los nacionales. La encuesta también señaló que los destinos europeos son los favoritos entre los viajeros de todos los grupos de edad, junto con Estados Unidos y Nueva Zelanda. Además, las estadísticas de Our World in Data, que recopila datos de la Organización Mundial del Turismo, mostraron un aumento del turismo en varias regiones en 2019, como la Unión Europea registró ~966,44 millones de llegadas, América del Norte registró ~200 millones de llegadas y Oriente Medio y Oriente Medio. ; El norte de África registró ~128 llegadas. Además, las llegadas a Francia ascendieron a 212 millones en 2018, mientras que otros países europeos como España registraron 126,17 millones de llegadas en 2019.
La Organización Mundial del Turismo de las Naciones Unidas (OMT) indicó un número creciente de llegadas, con 2.403 millones de llegadas en 2019 y un gasto estimado de 1.439 millones de dólares en turismo internacional. Si bien la pandemia de COVID-19 interrumpió enormemente esta tendencia, se espera que la implementación de campañas de vacunación contra la COVID-19 para las masas junto con las regulaciones de COVID-19 para viajes seguros ayuden a la normalización del turismo y los viajes. Durante el viaje, un viajero corre el riesgo de contraer enfermedades regionales, lo que puede provocar brotes o epidemias de enfermedades transnacionales. Por tanto, viajar fuera del país requiere la vacunación como medida de seguridad y precaución para evitar la propagación de este tipo de infecciones. Varios países tienen sus propios mandatos y regulaciones para proteger a sus ciudadanos de infecciones asociadas a viajes. Por ejemplo, el Servicio Nacional de Salud (NHS) del Reino Unido organiza un calendario de vacunación o inmunización de rutina para sus ciudadanos. Si una persona viaja fuera del Reino Unido, debe vacunarse para prevenir enfermedades infecciosas como la hepatitis A, la fiebre tifoidea y la fiebre amarilla. De manera similar, en Arabia Saudita, los viajeros que vienen de peregrinaciones al Hajj y la Umrah deben mostrar un comprobante de vacunación contra la meningitis y la influenza estacional. Muchos países exigen pruebas de vacunación obligatorias documentadas en un Certificado Internacional de Vacunación o Profilaxis (ICVP). Es necesaria la vacunación contra las enfermedades mencionadas en el HHS (Departamento de Salud y Servicios Humanos) de EE.UU. como varicela, cólera, COVID-19, difteria, influenza, Hepatitis A, Hepatitis B, tipo Haemophilus influenzae. B, virus del papiloma humano, encefalitis japonesa, sarampión, meningococo, paperas, neumococo, polio, rabia, rotavirus, rubéola, culebrilla, tétanos, fiebre tifoidea, tos ferina y fiebre amarilla, según el país de viaje. La preocupación por la propagación de enfermedades regionales entre países está impulsando la demanda del mercado de vacunas para viajes.
Información basada en el producto
Basado en el producto, El mercado mundial de vacunas para viajes se segmenta en hepatitis A, hepatitis B, vacunas meningocócicas, DPT, fiebre amarilla, tifoidea, encefalitis japonesa, sarampión, paperas y vacunas. rubéola, rabia, polio, influenza, varicela & culebrilla, cólera y otros. El segmento de la hepatitis A tuvo la mayor participación de mercado de vacunas para viajes en 2021. Si bien se espera que el segmento de la hepatitis A represente la mayor participación durante el período de pronóstico, se proyecta que el segmento DPT registre la CAGR más alta en el mercado de vacunas para viajes durante el pronóstico. período debido al creciente uso de la vacuna DPT antes de viajar. Se espera que esto ayude al uso de la vacuna DPT antes de viajar e impulse aún más el crecimiento del mercado de vacunas para viajes en los próximos años.
Mercado de vacunas para viajes, por producto: 2021 y 2028
Información basada en aplicaciones
Según la aplicación, el mercado se divide en viajes nacionales y emisores viajar. El segmento de viajes emisores tuvo una mayor participación de mercado en 2021 y se prevé que registre una CAGR más alta en el mercado durante el período de pronóstico. El aumento de los viajes por negocios, turismo y otros fines, como el turismo médico y la migración, está impulsando los viajes al exterior en todo el mundo, impulsando así la demanda de vacunas para viajes.
Las empresas suelen adoptar estrategias orgánicas para ampliar su huella y cartera de productos en el mercado. Además, las empresas han implementado diversas estrategias inorgánicas como fusiones, adquisiciones y asociaciones. Por ejemplo, en febrero de 2021, Dynavax Technologies Corporation anunció que la Comisión Europea (CE) otorgó la autorización de comercialización para HEPLISAV B [vacuna contra la hepatitis B (recombinante), con adyuvante] para la inmunización activa contra la infección por el virus de la hepatitis B (VHB) causada por todas las enfermedades conocidas. subtipos del virus de la hepatitis B en adultos de 18 años y más. La aprobación se emitió tras la opinión favorable de la Agencia Europea de Medicamentos (EMA) sobre la Solicitud de Autorización de Comercialización de la empresa.
Perfiles de la empresa
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Sanofi
- Novartis AG
- Pfizer Inc.
- Dynavax Technologies
- BioSoluciones emergentes Inc.
- Abbott
- Bharat Biotech
- Valneva SE
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The travel vaccines market majorly consists of the players such as GlaxoSmithKline plc; Merck & Co., Inc; Sanofi; Novartis AG; Pfizer Inc; Dynavax Technologies; Emergent BioSolutions Inc; Abbott; Bharat Biotech, and Valneva SE among others.
The travel vaccines market is analyzed in the basis of product and application. Based on product, is segmented into hepatitis A, hepatitis B, meningococcal infections, diphtheria pertussis tetanus (DPT), yellow fever typhoid, Japanese encephalitis, measles mumps & rubella, rabies, polio, influenza, varicella & shingles, cholera, and others. Among the product, the hepatitis A segment was dominating the market in 2021. And based on the application, outbound travel held the largest market for the market and is expected to continue its dominance in the coming future.
The factors that are driving the growth of the market are increasing travel and tourism, prevention of transnational infections, and growing incidences of infectious diseases. However, the high cost of travel vaccines is likely to hinder the market’s growth.
Travel vaccines, also called travel immunizations, are shots travelers can get before visiting certain areas of the world that help protect them from serious illnesses. Vaccinations work by exposing the body to germs or parts of germs of the disease it will protect against. Travel vaccines are safe, effective ways to help protect travelers from bringing home more than they bargained for. These vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travelers and to prevent disease spread within and between countries. Some countries require proof of vaccination for travelers wishing to enter or exit the country.
The List of Companies - Travel Vaccines Market
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Sanofi
- Novartis AG
- Pfizer Inc.
- Dynavax Technologies
- Emergent BioSolutions Inc.
- Abbott
- Bharat Biotech
- Valneva SE.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)